Benziodarone and 6-hydroxybenziodarone are potent and selective inhibitors of transthyretin amyloidogenesis
- 8 June 2023
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 90, 117370
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (JP20lm0203011)
- Japan Agency for Medical Research and Development (JP20am0101087)
- Paul Scherrer Institut (20191094)
- Paul Scherrer Institut (20191134)
- Japan Science and Technology Agency (JPMJSP2145)
- High Energy Accelerator Research Organization (2021G011)
- High Energy Accelerator Research Organization (2019G016)
This publication has 68 references indexed in Scilit:
- Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathyJournal of Neurology, 2013
- AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretinProceedings of the National Academy of Sciences, 2013
- Guideline of transthyretin-related hereditary amyloidosis for cliniciansOrphanet Journal of Rare Diseases, 2013
- Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without DementiaPLOS ONE, 2012
- Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascadeProceedings of the National Academy of Sciences, 2012
- Developing Potent Human Uric Acid Transporter 1 (hURAT1) InhibitorsJournal of Medicinal Chemistry, 2011
- A competition assay to identify amyloidogenesis inhibitors by monitoring the fluorescence emitted by the covalent attachment of a stilbene derivative to transthyretinBioorganic & Medicinal Chemistry, 2011
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004